Skip to main content

Table 7 Colonization characteristics in both studies conducted in AMOC, in children who were colonized with different Candida species

From: Changing face of Candida colonization pattern in pediatric patients with hematological malignancy during repeated hospitalizations, results of a prospective observational study (2016–2017) in shiraz, Iran

 

2017–2018

2011–2012 (18)

p-value c

N b

%

N b

%

Candida species a

     

C. Albicans

106

81.6

117

62

0.0003*

C. Krusei

7

5.4

18

9.6

0.2477

C. Parapsilosis

5

3.9

8

4.3

0.9126

C. Glabrata

4

3.1

14

7.5

0.1559

C. Kefyr

4

3.1

4

2.2

0.8893

C. Tropicalis

3

2.4

11

5.9

0.2262

C. Famata

1

0.8

11

5.9

0.0416*

Albicans versus non-Albicans Candida species

Albicans

106

81.6

117

62

0.0003*

Non-Albicans

24

18.5

72

38

0.0003*

Colonization site

     

Oral

98

75.4

88

38.4

< 0.0001*

Nasal

12

9.2

24

10.4

0.8560

Rectal

20

15.4

77

33.6

0.0003*

Urine

0

0

40

17.4

< 0.0001*

  1. a. Very rare species including C. guilliermondii, C. rugosa, C. Lusitaniae, C. lambica, and Rhodotorula spp. were excluded from 2011 to 2012 study
  2. b. Number of positive samples
  3. c. Chi-square test
  4. *Statistically significant